A woman who once collapsed mid-meal from sudden fainting spells can now eat a full dinner without fear, thanks to a heart procedure that rewires the nerves controlling her fainting reflex.
Quick Take
- Cardioneuroablation is a catheter-based procedure that targets nerve clusters on the heart to stop repeated fainting spells.
- The condition it treats, vasovagal syncope, causes sudden drops in heart rate and blood pressure that lead to fainting.
- Recent studies show freedom from fainting in roughly 88 to 94 percent of patients after the procedure.
- Mayo Clinic and other major research centers call it a promising option for patients who fail standard treatments.
- Doctors still want larger, sham-controlled trials before calling it a routine standard of care.
A Fainting Disorder That Upends Daily Life
Vasovagal syncope sounds harmless on paper. Mayo Clinic notes it usually requires no treatment at all. But for patients who faint again and again, often without warning, the condition steals independence. Eating a meal, standing in line, or simply sitting up can trigger a sudden crash in heart rate and blood pressure, sending them to the floor.
For most people, lifestyle changes and medication keep the fainting under control. A smaller group keeps fainting anyway, sometimes hard enough to cause injury. Doctors call this refractory vasovagal syncope, and it is this group that has pushed cardiologists to look for something more permanent than pills and hydration advice.
How Cardioneuroablation Targets the Problem at Its Source
Cardioneuroablation works by threading a catheter into the heart and burning small nerve clusters called ganglionated plexi. These clusters sit inside the heart’s own nervous system and help trigger the extreme vagal response that causes fainting. By disabling the overactive signals, doctors aim to stop the fainting reflex before it starts, rather than just managing it after the fact.
Mayo Clinic featured the procedure on its cardiovascular podcast, describing it as a promising new catheter ablation option for patients who have run out of other choices. The first reported case in the United States, published in the Journal of the American College of Cardiology, followed a patient who remained free of fainting spells eighteen months after the procedure.
What the Research Shows So Far
A 2025 randomized clinical trial compared two versions of the procedure, one targeting only the left side of the heart and one targeting both sides. Researchers found the left-sided approach worked just as well as the more extensive biatrial method, with efficacy rates of 87.5 percent and 90 percent. That result matters because it means doctors may be able to treat patients with a shorter, less invasive procedure.
A separate systematic review pooling more than 1,150 patients across 27 studies found the fainting recurrence rate after the procedure was under 6 percent. Another meta-analysis put freedom from fainting above 91 percent. Across multiple studies, complication rates stayed low, and researchers consistently reported improvements in how the heart’s autonomic nervous system regulated itself afterward.
Why Doctors Are Optimistic but Still Cautious
Cardiologists studying the procedure describe a familiar pattern in heart medicine. Early results look strong, complication rates stay low, and patients report real relief. But researchers still call for larger, sham-controlled, multicenter trials before treating cardioneuroablation as a routine standard of care. That caution reflects standard scientific practice, not doubt about what patients are experiencing.
Specialists note the procedure works best in a specific group: adults under 60 with severe, recurrent cardioinhibitory fainting who have already tried and failed conventional treatments. Age and patient selection matter, since data on older adults or those with different syncope patterns remains limited. Doctors emphasize that not every fainting patient is a candidate.
For patients who have spent years avoiding restaurants, standing in lines, or even sitting through church services out of fear of collapsing, a procedure that restores everyday confidence is not a small thing. It reflects a broader trend in cardiology toward precision, catheter-based fixes that target the exact nerve pathways causing a problem, rather than lifelong medication management. As more hospitals adopt the technique, patients who felt out of options may finally have one worth considering.
Sources:
youtube.com, pmc.ncbi.nlm.nih.gov, cardiovascularservices.mayoclinic.com, clinicaltrials.gov, mayoclinic.org, jacc.org
